LAROCHE RICHARD F JR 4
4 · NATIONAL HEALTHCARE CORP · Filed May 6, 2026
Research Summary
AI-generated summary of this filing
NHC Director Richard LaRoche Exercises Stock Options for $537K
What Happened
- Richard F. LaRoche Jr., a director of National Healthcare Corp (NHC), exercised stock options on 2026-05-05 to acquire 7,500 common shares at an exercise price of $71.64 per share, for a total cash outlay of $537,300. The filing also reports a contemporaneous derivative disposition of 7,500 shares at $0.00 (no cash proceeds reported).
Key Details
- Transaction date: 2026-05-05; Filing date: 2026-05-06 (appears timely).
- Acquired: 7,500 shares via option exercise at $71.64/share (total $537,300).
- Disposed: 7,500 derivative shares at $0.00 (no cash proceeds shown).
- Shares owned after the transaction: not specified in the excerpt provided.
- Footnote: The options were granted under the 2020 Omnibus Equity Incentive Plan on May 6, 2021; the grant and exercise are reported as exempt from Section 16(b) under Rule 16b-3(d).
Context
- This filing documents an options exercise (insider acquisition of shares). The report does not show an open-market sale of the shares for cash. The $0.00 derivative disposition is reported in the Form 4 but the filing does not specify whether shares were surrendered or withheld to satisfy exercise costs or tax obligations.
Insider Transaction Report
Form 4
LAROCHE RICHARD F JR
Director
Transactions
- Exercise/Conversion
Common Stock - Held in my name or my wife's name
[F1]2026-05-05$71.64/sh+7,500$537,300→ 213,260 total - Exercise/Conversion
Option to Purchase Common Stock [2021 Grant]
[F1]2026-05-05−7,500→ 0 totalExercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (7,500 underlying)
Holdings
- 7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2023 Grant]
Exercise: $55.75From: 2025-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2024 Grant]
Exercise: $96.03From: 2024-05-09Exp: 2029-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2025 Grant]
Exercise: $94.66From: 2026-05-08Exp: 2030-05-07→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Signature
/s/ Richard LaRoche|2026-05-06